Chronic Leukemia Perspective
- Episode 6: Bruton Tyrosine Kinase Inhibitors in Mantle Cell Lymphoma
- Racial Disparities in CLL: Underrepresentation in Clinical Trials
- A Path to a Career in CLL Clinical Research
- Improving Quality of Life in Patients With CLL: Managing Side Effects From Targeted Therapy
- The Costs of Disparities in the Treatment of Chronic Lymphocytic Leukemia
- How Collaboration Builds Better Treatments for Chronic Lymphocytic Leukemia
- Learning to Appreciate the Impact of CLL on the Lives of Patients
- Taking the Long View in the Treatment of CLL
- Episode 5: Key Topics in the Pathology of Mantle Cell Lymphoma
- Episode 1: Autologous Stem Cell Transplant for Mantle Cell Lymphoma
- Chronic Lymphocytic Leukemia Highlights From ASH 2022
- CLL e-Tumor Boards: Case 2: Relapsed Chronic Lymphocytic Leukemia
- Paxlovid Rebound in COVID-19: Where We Stand on Drug Regimens
- Is the Phrase 'A Cure for Cancer' Outdated?
- CLL e-Tumor Boards: Case 1: Stage II Chronic Lymphocytic Leukemia
- EHA 2022
- Episode 1: Screening for Early-Stage Multiple Myeloma
- Outlook on Chronic Lymphocytic Leukemia: How Clinical Trials Can Improve Patient Outcomes
- How Experiences With Richter Transformation Shaped a Clinician's Day-to-Day Practice
- Outlook on Chronic Lymphocytic Leukemia: From Theory to Practice